The zoonotic pathogen Wohlfahrtiimonas chitiniclastica – current findings from a clinical and genomic perspective

Publikation: Beitrag in FachzeitschriftÜbersichtsartikel (Review)BeigetragenBegutachtung

Beitragende

  • Anna Kopf - , Sana-Herzzentrum Cottbus (Autor:in)
  • Boyke Bunk - , Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures (Autor:in)
  • Thomas Riedel - , Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures (Autor:in)
  • Percy Schröttner - , Institut für Klinische Chemie und Laboratoriumsmedizin (Autor:in)

Abstract

The zoonotic pathogen Wohlfahrtiimonas chitiniclastica can cause several diseases in humans, including sepsis and bacteremia. Although the pathogenesis is not fully understood, the bacterium is thought to enter traumatic skin lesions via fly larvae, resulting in severe myiasis and/or wound contamination. Infections are typically associated with, but not limited to, infestation of an open wound by fly larvae, poor sanitary conditions, cardiovascular disease, substance abuse, and osteomyelitis. W. chitiniclastica is generally sensitive to a broad spectrum of antibiotics with the exception of fosfomycin. However, increasing drug resistance has been observed and its development should be monitored with caution. In this review, we summarize the currently available knowledge and evaluate it from both a clinical and a genomic perspective.

Details

OriginalspracheEnglisch
Aufsatznummer3
Seiten (von - bis)3
FachzeitschriftBMC Microbiology
Jahrgang24
Ausgabenummer1
PublikationsstatusVeröffentlicht - 3 Jan. 2024
Peer-Review-StatusJa

Externe IDs

PubMed 38172653
Scopus 85181233189

Schlagworte

Ziele für nachhaltige Entwicklung

Schlagwörter

  • Animals, Gammaproteobacteria/genetics, Larva, Humans, Genomics, Diptera/microbiology, Anti-Bacterial Agents/pharmacology